JAK Inhibitors for Alopecia Areata: Selectivity Meets Pivotal Trial Efficacy
Dermatology Times reviews JAK inhibitors for alopecia areata, pairing kinase selectivity profiles with pivotal trial efficacy data to guide agent selection.
Topic
Drug Selectivity
Topic